Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	estrogen catabolic process	UGT1A8 UGT1A7 UGT1A9	1.86e-06	5	119	3	GO:0006711
GeneOntologyBiologicalProcess	flavonoid glucuronidation	UGT1A8 UGT1A7 UGT1A9	1.86e-06	5	119	3	GO:0052696
GeneOntologyBiologicalProcess	regulation of chromatin organization	TLK2 SSRP1 TLK1 TASOR DNMT3L	3.29e-06	40	119	5	GO:1902275
GeneOntologyBiologicalProcess	phenylpropanoid catabolic process	UGT1A8 UGT1A7 UGT1A9	3.70e-06	6	119	3	GO:0046271
GeneOntologyBiologicalProcess	coumarin catabolic process	UGT1A8 UGT1A7 UGT1A9	3.70e-06	6	119	3	GO:0046226
GeneOntologyBiologicalProcess	flavone metabolic process	UGT1A8 UGT1A7 UGT1A9	3.70e-06	6	119	3	GO:0051552
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	UGT1A8 UGT1A7 UGT1A9	2.18e-05	10	119	3	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	UGT1A8 UGT1A7 UGT1A9	2.18e-05	10	119	3	GO:0009804
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT1A8 UGT1A7 UGT1A9	3.97e-05	12	119	3	GO:0052697
GeneOntologyBiologicalProcess	flavonoid metabolic process	UGT1A8 UGT1A7 UGT1A9	5.13e-05	13	119	3	GO:0009812
GeneOntologyBiologicalProcess	macrophage migration	MYO9B BCR PTK2B PTPRJ C5	9.42e-05	79	119	5	GO:1905517
GeneOntologyBiologicalProcess	chromatin organization	TLK2 SET PIWIL4 CHD4 SSRP1 TLK1 MTA1 MTA3 EHMT2 SETSIP BRPF1 ATM GNAS TASOR DNMT3L	2.01e-04	896	119	15	GO:0006325
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT1A8 UGT1A7 UGT1A9	2.31e-04	21	119	3	GO:0052695
GeneOntologyBiologicalProcess	hormone catabolic process	UGT1A8 UGT1A7 UGT1A9	2.31e-04	21	119	3	GO:0042447
GeneOntologyCellularComponent	RAVE complex	DMXL2 DMXL1	9.60e-05	3	119	2	GO:0043291
GeneOntologyCellularComponent	CHD-type complex	CHD4 MTA1 MTA3	1.15e-04	17	119	3	GO:0090545
GeneOntologyCellularComponent	NuRD complex	CHD4 MTA1 MTA3	1.15e-04	17	119	3	GO:0016581
GeneOntologyCellularComponent	postsynaptic specialization, intracellular component	SRC GRIN2B BCR PTK2B	2.92e-04	56	119	4	GO:0099091
GeneOntologyCellularComponent	postsynaptic specialization	SEMA4F ANK3 SRC GRIA2 GRIN2B BCR PTK2B SLC8A2 MKLN1 SORCS3	6.09e-04	503	119	10	GO:0099572
GeneOntologyCellularComponent	membrane attack complex	C5 C8B	6.62e-04	7	119	2	GO:0005579
GeneOntologyCellularComponent	sarcolemma	ANK3 LAMA2 SLC8A2 SCN5A SGCE GNAS	7.73e-04	190	119	6	GO:0042383
GeneOntologyCellularComponent	neuron to neuron synapse	SEMA4F ANK3 GRIA2 CHD4 GRIN2B BCR PTK2B SLC8A2 MKLN1 SORCS3	8.21e-04	523	119	10	GO:0098984
GeneOntologyCellularComponent	NMDA selective glutamate receptor complex	GRIN2B PTK2B	1.13e-03	9	119	2	GO:0017146
GeneOntologyCellularComponent	dendrite	SEMA4F ANK3 SRC LAMA2 GRIA2 GRIN2B ADNP BCR FZD4 PTK2B SLC8A2 SGCE GNAS	1.21e-03	858	119	13	GO:0030425
GeneOntologyCellularComponent	dendritic tree	SEMA4F ANK3 SRC LAMA2 GRIA2 GRIN2B ADNP BCR FZD4 PTK2B SLC8A2 SGCE GNAS	1.24e-03	860	119	13	GO:0097447
GeneOntologyCellularComponent	asymmetric synapse	SEMA4F ANK3 GRIA2 CHD4 GRIN2B BCR PTK2B SLC8A2 SORCS3	1.64e-03	477	119	9	GO:0032279
Domain	Rav1p_C	DMXL2 DMXL1	3.69e-05	2	114	2	IPR022033
Domain	Rav1p_C	DMXL2 DMXL1	3.69e-05	2	114	2	PF12234
Domain	SEA	TMPRSS15 TMPRSS11F ADGRF5	7.68e-05	14	114	3	SM00200
Domain	-	TMPRSS15 TMPRSS11F ADGRF5	9.55e-05	15	114	3	3.30.70.960
Domain	UDPGT	UGT1A8 UGT1A7 UGT1A9	2.72e-04	21	114	3	PF00201
Domain	UDPGT	UGT1A8 UGT1A7 UGT1A9	2.72e-04	21	114	3	PS00375
Domain	UDP_glucos_trans	UGT1A8 UGT1A7 UGT1A9	2.72e-04	21	114	3	IPR002213
Domain	SEA	TMPRSS15 TMPRSS11F ADGRF5	3.13e-04	22	114	3	PF01390
Domain	SEA	TMPRSS15 TMPRSS11F ADGRF5	3.59e-04	23	114	3	PS50024
Domain	SEA_dom	TMPRSS15 TMPRSS11F ADGRF5	3.59e-04	23	114	3	IPR000082
Domain	Na_trans_cytopl	SCN5A SCN9A	5.45e-04	6	114	2	PF11933
Domain	Na_trans_cytopl	SCN5A SCN9A	5.45e-04	6	114	2	IPR024583
Domain	IQ	MYO9B ADGB SCN5A SCN9A	1.53e-03	81	114	4	SM00015
Domain	Na_channel_asu	SCN5A SCN9A	1.61e-03	10	114	2	IPR001696
Domain	Na_trans_assoc	SCN5A SCN9A	1.61e-03	10	114	2	IPR010526
Domain	Na_trans_assoc	SCN5A SCN9A	1.61e-03	10	114	2	PF06512
Domain	BAH	MTA1 MTA3	1.96e-03	11	114	2	PS51038
Domain	BAH_dom	MTA1 MTA3	1.96e-03	11	114	2	IPR001025
Domain	BAH	MTA1 MTA3	1.96e-03	11	114	2	SM00439
Domain	BAH	MTA1 MTA3	1.96e-03	11	114	2	PF01426
Domain	IQ_motif_EF-hand-BS	MYO9B ADGB SCN5A SCN9A	2.25e-03	90	114	4	IPR000048
Domain	ZnF_GATA	MTA1 MTA3	2.34e-03	12	114	2	SM00401
Domain	IQ	MYO9B ADGB SCN5A SCN9A	2.53e-03	93	114	4	PS50096
Domain	ELM2_dom	MTA1 MTA3	2.76e-03	13	114	2	IPR000949
Domain	ELM2	MTA1 MTA3	2.76e-03	13	114	2	PF01448
Domain	ELM2	MTA1 MTA3	2.76e-03	13	114	2	PS51156
Domain	ELM2	MTA1 MTA3	2.76e-03	13	114	2	SM01189
Domain	-	ATRN KLHL15 MKLN1	3.14e-03	48	114	3	2.120.10.80
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH7	3.20e-03	14	114	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH7	3.20e-03	14	114	2	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH7	3.20e-03	14	114	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH7	3.20e-03	14	114	2	PF08393
Domain	MT	DYNC2H1 DNAH7	3.20e-03	14	114	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH7	3.20e-03	14	114	2	PF12780
Domain	CUB	ATRN TMPRSS15 BMP1	3.33e-03	49	114	3	PF00431
Domain	CUB	ATRN TMPRSS15 BMP1	3.52e-03	50	114	3	SM00042
Domain	DHC_fam	DYNC2H1 DNAH7	3.68e-03	15	114	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH7	3.68e-03	15	114	2	PF03028
Domain	Znf_GATA	MTA1 MTA3	3.68e-03	15	114	2	IPR000679
Domain	GATA	MTA1 MTA3	3.68e-03	15	114	2	PF00320
Domain	Dynein_heavy_dom	DYNC2H1 DNAH7	3.68e-03	15	114	2	IPR004273
Domain	-	ATRN TMPRSS15 BMP1	3.94e-03	52	114	3	2.60.120.290
Domain	CUB	ATRN TMPRSS15 BMP1	4.16e-03	53	114	3	PS01180
Domain	GATA_ZN_FINGER_1	MTA1 MTA3	4.19e-03	16	114	2	PS00344
Domain	GATA_ZN_FINGER_2	MTA1 MTA3	4.19e-03	16	114	2	PS50114
Domain	EGF-like_dom	ATRN LAMA2 BMP1 TENM4 HMCN1 C8B	4.26e-03	249	114	6	IPR000742
Domain	-	SEMA4F FBXW10B DMXL2 FBXW10 DMXL1 LLGL2 WDFY3	4.35e-03	333	114	7	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	SEMA4F FBXW10B DMXL2 FBXW10 DMXL1 LLGL2 WDFY3	4.49e-03	335	114	7	IPR015943
Domain	PH_dom-like	RASA2 DOCK11 SSRP1 BCR PLEKHD1 MTMR10 PTK2B WDFY3	4.61e-03	426	114	8	IPR011993
Domain	Kelch-typ_b-propeller	ATRN KLHL15 MKLN1	4.61e-03	55	114	3	IPR015915
Domain	NAP_family	SET SETSIP	4.73e-03	17	114	2	IPR002164
Domain	NAP	SET SETSIP	4.73e-03	17	114	2	PF00956
Domain	EGF_1	ATRN LAMA2 BMP1 TENM4 HMCN1 C8B	4.78e-03	255	114	6	PS00022
Domain	CUB_dom	ATRN TMPRSS15 BMP1	5.10e-03	57	114	3	IPR000859
Domain	WD40	FBXW10B DMXL2 FBXW10 DMXL1 LLGL2 WDFY3	5.15e-03	259	114	6	PF00400
Domain	Lig_chan-Glu_bd	GRIA2 GRIN2B	5.30e-03	18	114	2	PF10613
Domain	Glu/Gly-bd	GRIA2 GRIN2B	5.30e-03	18	114	2	IPR019594
Domain	Lig_chan-Glu_bd	GRIA2 GRIN2B	5.30e-03	18	114	2	SM00918
Domain	Iontro_rcpt	GRIA2 GRIN2B	5.30e-03	18	114	2	IPR001320
Domain	Iono_rcpt_met	GRIA2 GRIN2B	5.30e-03	18	114	2	IPR001508
Domain	Lig_chan	GRIA2 GRIN2B	5.30e-03	18	114	2	PF00060
Domain	PBPe	GRIA2 GRIN2B	5.30e-03	18	114	2	SM00079
Domain	EGF-like_CS	ATRN LAMA2 BMP1 TENM4 HMCN1 C8B	5.34e-03	261	114	6	IPR013032
Domain	EGF_2	ATRN LAMA2 BMP1 TENM4 HMCN1 C8B	5.74e-03	265	114	6	PS01186
Domain	GPCR_2_secretin-like	VIPR1 FZD4 ADGRF5	5.89e-03	60	114	3	IPR000832
Domain	GPCR_2-like	VIPR1 FZD4 ADGRF5	5.89e-03	60	114	3	IPR017981
Domain	WD40	FBXW10B DMXL2 FBXW10 DMXL1 LLGL2 WDFY3	6.06e-03	268	114	6	SM00320
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	PIWIL4 CHD4 MTA1 MTA3 EHMT2 TASOR DNMT3L	2.33e-05	142	85	7	M48257
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-43 IGHV3-23 IGHV3-64D C5 C8B	1.50e-04	84	85	5	MM14653
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	CHD4 MTA1 MTA3 EHMT2	1.80e-04	47	85	4	M1095
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	CHD4 MTA1 MTA3 EHMT2	1.80e-04	47	85	4	MM15428
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-43 IGHV3-23 SRC IGHV3-64D	1.96e-04	48	85	4	MM17214
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	PIWIL4 CHD4 MTA1 MTA3 DNMT3L	2.95e-04	97	85	5	M48262
Pathway	WP_ESTROGEN_METABOLISM	UGT1A8 UGT1A7 UGT1A9	3.00e-04	22	85	3	MM15888
Pathway	REACTOME_LONG_TERM_POTENTIATION	SRC GRIA2 GRIN2B	3.43e-04	23	85	3	M27949
Pathway	REACTOME_GLUCURONIDATION	UGT1A8 UGT1A7 UGT1A9	3.91e-04	24	85	3	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT1A8 UGT1A7 UGT1A9	4.42e-04	25	85	3	M17787
Pathway	WP_GLUCURONIDATION	UGT1A8 UGT1A7 UGT1A9	4.42e-04	25	85	3	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT1A8 UGT1A7 UGT1A9	4.42e-04	25	85	3	M605
Pubmed	Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.	UGT1A8 UGT1A7 UGT1A9 TKTL1	6.98e-08	12	122	4	19419973
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SET TUT4 RBBP6 RHOBTB3 CHD4 SSRP1 SKI BCR MTA1 MTA3 EHMT2 SETSIP TYW5 BRPF1 SCN5A WDFY3 TMX3 ALG13	7.32e-08	1116	122	18	31753913
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	RBBP6 CHD4 SSRP1 ADNP MTA1 MTA3 EHMT2	8.24e-08	103	122	7	32744500
Pubmed	Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.	UGT1A8 UGT1A7 UGT1A9	4.19e-07	5	122	3	20565459
Pubmed	Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice.	UGT1A8 UGT1A7 UGT1A9	8.36e-07	6	122	3	32527940
Pubmed	Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint.	TLK2 TLK1 ATM	8.36e-07	6	122	3	12660173
Pubmed	Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.	UGT1A8 UGT1A7 UGT1A9	8.36e-07	6	122	3	20297805
Pubmed	Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	UGT1A8 UGT1A7 UGT1A9	1.46e-06	7	122	3	8467709
Pubmed	Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).	UGT1A8 UGT1A7 UGT1A9	1.46e-06	7	122	3	8464825
Pubmed	Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.	UGT1A8 UGT1A7 UGT1A9	1.46e-06	7	122	3	27514509
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TLK2 FBXW10B DMXL2 FBXW10 TUT4 SRC USP24 DMXL1 PTK2B TLK1 LLGL2 EHMT2 MAPK6	1.86e-06	730	122	13	34857952
Pubmed	Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.	UGT1A8 UGT1A7 UGT1A9	2.33e-06	8	122	3	20610558
Pubmed	Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.	UGT1A8 UGT1A7 UGT1A9	2.33e-06	8	122	3	18052087
Pubmed	Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.	UGT1A8 UGT1A7 UGT1A9	2.33e-06	8	122	3	17179145
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	TUT4 DYNC2H1 PIWIL4 CHD4 COL22A1 SSRP1 BCR ADGB TOMM70 EHMT2 SETSIP RAB1B TASOR	2.65e-06	754	122	13	35906200
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SET ANKRD30B GRIA2 CHD4 TKTL1 STOX1 SSRP1 SKI LRRC43 TTC3 RFTN1 TLK1 SETSIP SCN9A RAB1B ATM MAPK6 TASOR	2.95e-06	1442	122	18	35575683
Pubmed	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	UGT1A8 UGT1A7 UGT1A9	3.48e-06	9	122	3	22511988
Pubmed	RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene.	CHD4 MTA1 MTA3	3.48e-06	9	122	3	22926524
Pubmed	Comparative analysis of human chromosome 7q21 and mouse proximal chromosome 6 reveals a placental-specific imprinted gene, TFPI2/Tfpi2, which requires EHMT2 and EED for allelic-silencing.	EHMT2 SGCE DNMT3L	3.48e-06	9	122	3	18480470
Pubmed	Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis.	MTA1 MTA3 EHMT2	3.48e-06	9	122	3	26028330
Pubmed	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	UGT1A8 UGT1A7 UGT1A9	4.96e-06	10	122	3	23642732
Pubmed	UDP-glucuronosyltransferases.	UGT1A8 UGT1A7 UGT1A9	4.96e-06	10	122	3	11465080
Pubmed	A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.	UGT1A8 UGT1A7 UGT1A9	4.96e-06	10	122	3	23371916
Pubmed	A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.	UGT1A8 UGT1A7 UGT1A9	4.96e-06	10	122	3	22558097
Pubmed	Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.	UGT1A8 UGT1A7 UGT1A9	6.81e-06	11	122	3	18695635
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	CHD4 DNAH7 MTA1 MTA3 BRPF1	6.94e-06	75	122	5	25593309
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TLK2 DMXL2 ANK3 DOCK11 SRC GRIA2 CHD4 GRIN2B ADNP TTC3 BCR SH3PXD2B EHMT2 WDFY3	7.60e-06	963	122	14	28671696
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT1A8 UGT1A7 UGT1A9	9.05e-06	12	122	3	20308471
Pubmed	Metastasis tumor antigen 2 (MTA2) is involved in proper imprinted expression of H19 and Peg3 during mouse preimplantation development.	CHD4 MTA1 MTA3	9.05e-06	12	122	3	20720167
Pubmed	The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.	CHD4 MTA1 EHMT2	9.05e-06	12	122	3	23708667
Pubmed	NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.	CHD4 MTA1 MTA3	9.05e-06	12	122	3	22560079
Pubmed	Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.	UGT1A8 UGT1A7 UGT1A9	9.05e-06	12	122	3	11434514
Pubmed	Cross-linking mass spectrometry reveals the structural topology of peripheral NuRD subunits relative to the core complex.	CHD4 ADNP MTA1 MTA3	9.70e-06	38	122	4	33283408
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DMXL2 DYNC2H1 RNPC3 ABRAXAS2 RFTN1 TLK1 RADIL SAMD9L ADGRF5 TASOR	1.00e-05	493	122	10	15368895
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	DMXL2 SET MAN2A2 LAMA2 CHD4 SSR4 TTC3 TOMM70 EHMT2 MKLN1	1.07e-05	497	122	10	23414517
Pubmed	Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain.	ANK3 SRC MTA3 ATM	1.08e-05	39	122	4	22802532
Pubmed	LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.	CHD4 MTA1 MTA3	1.17e-05	13	122	3	19703393
Pubmed	The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity.	CHD4 MTA1 MTA3	1.17e-05	13	122	3	12920132
Pubmed	UGT1A1 is a major locus influencing bilirubin levels in African Americans.	UGT1A8 UGT1A7 UGT1A9	1.17e-05	13	122	3	22085899
Pubmed	Genome-wide analysis of hepatic lipid content in extreme obesity.	UGT1A8 UGT1A7 UGT1A9	1.17e-05	13	122	3	25246029
Pubmed	A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation.	SRC PTK2B	1.22e-05	2	122	2	8849729
Pubmed	The expression of Tousled kinases in CaP cell lines and its relation to radiation response and DSB repair.	TLK2 TLK1	1.22e-05	2	122	2	21647934
Pubmed	Development of vascular renin expression in the kidney critically depends on the cyclic AMP pathway.	REN GNAS	1.22e-05	2	122	2	19261741
Pubmed	Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology.	SRC GRIN2B	1.22e-05	2	122	2	26252487
Pubmed	Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres.	TLK2 TLK1	1.22e-05	2	122	2	32755577
Pubmed	Activation of protein tyrosine kinase PYK2 by the m1 muscarinic acetylcholine receptor.	SRC PTK2B	1.22e-05	2	122	2	9560226
Pubmed	cDNA cloning and chromosomal mapping of genes encoding novel protein kinases termed PKU-alpha and PKU-beta, which have nuclear localization signal.	TLK2 TLK1	1.22e-05	2	122	2	9427565
Pubmed	Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.	UGT1A7 UGT1A9	1.22e-05	2	122	2	11677206
Pubmed	Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.	SRC GNAS	1.22e-05	2	122	2	38097740
Pubmed	Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.	UGT1A7 UGT1A9	1.22e-05	2	122	2	12944498
Pubmed	Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.	UGT1A7 UGT1A9	1.22e-05	2	122	2	17529886
Pubmed	The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells.	MTA1 MTA3	1.22e-05	2	122	2	19363681
Pubmed	Expression of the transmembrane lysosomal protein SCARB2/Limp-2 in renin secretory granules controls renin release.	REN SCARB2	1.22e-05	2	122	2	23635510
Pubmed	Kinetic Analysis of Membrane Potential Dye Response to NaV1.7 Channel Activation Identifies Antagonists with Pharmacological Selectivity against NaV1.5.	SCN5A SCN9A	1.22e-05	2	122	2	26861708
Pubmed	ATM mediated phosphorylation of CHD4 contributes to genome maintenance.	CHD4 ATM	1.22e-05	2	122	2	21219611
Pubmed	FBXW10 promotes hepatocarcinogenesis in male patients and mice.	FBXW10B FBXW10	1.22e-05	2	122	2	31400758
Pubmed	Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.	MTA1 MTA3	1.22e-05	2	122	2	25319202
Pubmed	Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.	FBXW10B FBXW10	1.22e-05	2	122	2	37450367
Pubmed	Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gsalpha in juxtaglomerular cells.	REN GNAS	1.22e-05	2	122	2	16822937
Pubmed	Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.	UGT1A8 UGT1A9	1.22e-05	2	122	2	18568343
Pubmed	UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.	UGT1A7 UGT1A9	1.22e-05	2	122	2	15709193
Pubmed	Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities.	SRC PTK2B	1.22e-05	2	122	2	26743491
Pubmed	Novel Role of Src in Priming Pyk2 Phosphorylation.	SRC PTK2B	1.22e-05	2	122	2	26866924
Pubmed	p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells.	BCR PTK2B	1.22e-05	2	122	2	14961028
Pubmed	c-Src and Pyk2 protein tyrosine kinases play protective roles in early HIV-1 infection of CD4+ T-cell lines.	SRC PTK2B	1.22e-05	2	122	2	24413044
Pubmed	Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.	UGT1A8 UGT1A7 UGT1A9	1.49e-05	14	122	3	21646302
Pubmed	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	UGT1A8 UGT1A7 UGT1A9	1.49e-05	14	122	3	10836148
Pubmed	MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.	CHD4 MTA1 MTA3	1.49e-05	14	122	3	16428440
Pubmed	NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.	CHD4 MTA1 MTA3	1.49e-05	14	122	3	25150861
Pubmed	The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.	UGT1A8 UGT1A7 UGT1A9	1.49e-05	14	122	3	9295054
Pubmed	Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.	UGT1A8 UGT1A7 UGT1A9	1.49e-05	14	122	3	14672974
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	SET CHD4 ADNP MTA1 MTA3 EHMT2	1.56e-05	150	122	6	28242625
Pubmed	An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.	CHD4 SSRP1 MTA1 MTA3 DNMT3L	1.79e-05	91	122	5	20362542
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATRN VIPR1 TUT4 ANK3 RASA2 PCDH11Y SRC SKI TTC3 BCR TLK1 MTA3 PTPRJ MKLN1 GNAS MAPK6 TMX3	1.82e-05	1489	122	17	28611215
Pubmed	1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.	IGHV3-43 IGHV3-23 IGHV3-64D	1.86e-05	15	122	3	12657787
Pubmed	The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.	CHD4 MTA1 MTA3	1.86e-05	15	122	3	25247294
Pubmed	NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development.	CHD4 MTA1 MTA3	1.86e-05	15	122	3	19927129
Pubmed	Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.	CHD4 MTA1 MTA3 EHMT2	1.92e-05	45	122	4	21258344
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	CHD4 SSRP1 MTA1 MTA3 EHMT2 BRPF1	2.02e-05	157	122	6	30186101
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ATRN MAN2A2 DPY19L1 GLB1L2 SSR4 DMXL1 BMP1 COCH PTPRJ SCARB2 LRRC8A SGCE ATM TMX3 TMEM258	2.11e-05	1201	122	15	35696571
Pubmed	Genome-wide association meta-analysis for total serum bilirubin levels.	UGT1A8 UGT1A7 UGT1A9	2.28e-05	16	122	3	19414484
Pubmed	Genome-wide association of serum bilirubin levels in Korean population.	UGT1A8 UGT1A7 UGT1A9	2.76e-05	17	122	3	20639394
Pubmed	Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.	RBBP6 BCR RADIL SH3PXD2B PTPRJ	3.25e-05	103	122	5	21706016
Pubmed	The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.	CHD4 MTA1 MTA3	3.31e-05	18	122	3	9790534
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	UGT1A8 UGT1A7 UGT1A9	3.31e-05	18	122	3	20056724
Pubmed	Mi-2/NuRD is required in renal progenitor cells during embryonic kidney development.	CHD4 MTA1 MTA3	3.31e-05	18	122	3	23201013
Pubmed	Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.	CHD4 MTA1 MTA3	3.31e-05	18	122	3	10444591
Pubmed	MicroRNA-223 is neuroprotective by targeting glutamate receptors.	GRIA2 GRIN2B	3.65e-05	3	122	2	23112146
Pubmed	Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways.	SRC PTK2B	3.65e-05	3	122	2	25216923
Pubmed	Knocking down low molecular weight protein tyrosine phosphatase (LMW-PTP) reverts chemoresistance through inactivation of Src and Bcr-Abl proteins.	SRC BCR	3.65e-05	3	122	2	22957062
Pubmed	Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation.	TLK2 TLK1	3.65e-05	3	122	2	28535374
Pubmed	Obsessive-compulsive disorder, which genes? Which functions? Which pathways? An integrated holistic view regarding OCD and its complex genetic etiology.	GRIA2 GRIN2B	3.65e-05	3	122	2	28608743
Pubmed	Severe hypoxia increases expression of ATM and DNA-PKcs and it increases their activities through Src and AMPK signaling pathways.	SRC ATM	3.65e-05	3	122	2	30224064
Pubmed	Identification of G-proteins coupling to the vasoactive intestinal peptide receptor VPAC(1) using immunoaffinity chromatography: evidence for precoupling.	VIPR1 GNAS	3.65e-05	3	122	2	11812005
Pubmed	Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.	UGT1A7 UGT1A9	3.65e-05	3	122	2	16636344
Pubmed	A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice.	PIWIL4 DNMT3L	3.65e-05	3	122	2	18922463
Pubmed	Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca2+, PYK-2, and p60(src).	SRC PTK2B	3.65e-05	3	122	2	10777553
Pubmed	Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.	SRC PTK2B	3.65e-05	3	122	2	25834823
Pubmed	UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.	UGT1A8 UGT1A9	3.65e-05	3	122	2	19225446
Pubmed	DNA methylation restrains transposons from adopting a chromatin signature permissive for meiotic recombination.	PIWIL4 DNMT3L	3.65e-05	3	122	2	26109049
Interaction	UGT1A7 interactions	MAN2A2 UGT1A8 UGT1A7 SRC UGT1A9 GLB1L2 TMX3	4.09e-08	57	118	7	int:UGT1A7
Interaction	TMEM30B interactions	SEMA4F GLB1L2 KLHL15 LRRC8A SGCE PCDH10	1.06e-05	85	118	6	int:TMEM30B
Interaction	SCN1A interactions	ANK3 GRIN2B SCN5A SCN9A	2.37e-05	29	118	4	int:SCN1A
Cytoband	2q37	UGT1A8 UGT1A7 UGT1A9	7.61e-05	31	121	3	2q37
GeneFamily	PHD finger proteins\|NuRD complex	CHD4 MTA1 MTA3	2.37e-05	12	88	3	1305
GeneFamily	UDP glucuronosyltransferases	UGT1A8 UGT1A7 UGT1A9	4.99e-04	32	88	3	363
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN5A SCN9A	8.25e-04	9	88	2	1203
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW10B FBXW10	1.25e-03	11	88	2	559
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH10	1.50e-03	12	88	2	21
GeneFamily	WD repeat domain containing	FBXW10B DMXL2 FBXW10 DMXL1 LLGL2 WDFY3	1.76e-03	262	88	6	362
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA1 MTA3	2.36e-03	15	88	2	82
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATRN ANK3 DYNC2H1 RNPC3 RHOBTB3 USP24 PLEKHD1 FZD4 HMCN1	3.10e-09	195	120	9	a38d9dc6192aea673d96fda6b25e81223fda3abf
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 COL22A1 GRIN2B TENM4 HMCN1 SCN9A PCDH10	6.88e-07	184	120	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 COL22A1 GRIN2B TENM4 HMCN1 SCN9A PCDH10	6.88e-07	184	120	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 COL22A1 GRIN2B TENM4 HMCN1 SCN9A PCDH10	6.88e-07	184	120	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Striatum-Neuronal-Excitatory\|Striatum / BrainAtlas - Mouse McCarroll V32	VIPR1 GRIA2 GRIN2B PTK2B TOMM70 SLC8A2 LSM14B	1.05e-06	196	120	7	67400193ba469cf4d939e94f5ed94995e384bc07
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RHOBTB3 PLEKHD1 FZD4 LLGL2 HMCN1	8.58e-06	177	120	6	c9e8149639551a4c8daa90fcb2b895fdcff2e2ba
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 GRIA2 DNAH7 ADGB KY SLC8A2	9.15e-06	179	120	6	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RHOBTB3 USP24 PLEKHD1 LLGL2 HMCN1	9.15e-06	179	120	6	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RNPC3 RHOBTB3 USP24 LLGL2 HMCN1	1.04e-05	183	120	6	2e831a4d99c6f983793df71c0994124c943c6da9
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 LAMA2 GRIA2 GNAS C8B CCDC33	1.10e-05	185	120	6	4e40d3103ebf4a7066b7ce300b6ef700ba0e2863
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 SSR4 BMP1 LAMP3 C5 TMEM258	1.10e-05	185	120	6	929b68b05b7686341329ac756d7df172cb4b810b
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIPR1 DOCK11 LAMA2 GRIA2 GNAS C8B	1.25e-05	189	120	6	ce3fbaf9642785c8adf6edaeae20998bca558928
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RNPC3 USP24 PLEKHD1 LLGL2 HMCN1	1.25e-05	189	120	6	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RNPC3 USP24 PLEKHD1 LLGL2 HMCN1	1.25e-05	189	120	6	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANK3 DYNC2H1 STOX1 DNAH7 ADGB CCDC33	1.40e-05	193	120	6	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DENND5B IGHV3-43 IGHV3-23 SSR4 TMEM258 IGHV3-72	1.40e-05	193	120	6	7b4b0271e4fbece703876acb053ae236afb7cdba
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 TTC3 COCH TENM4 SCN5A GNAS	1.40e-05	193	120	6	1aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 STOX1 DNAH7 ADGB EFHC2 CCDC33	1.44e-05	194	120	6	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DENND5B IGHV3-43 IGHV3-23 SSR4 TMEM258 IGHV3-72	1.53e-05	196	120	6	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DMXL2 DOCK11 MYO9B SH3PXD2B SAMD9L SCARB2	1.67e-05	199	120	6	155b03b859157013e9142e9248551369127d9204
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	VIPR1 FZD4 SAMD9L SCN9A LRRC8A ADGRF5	1.72e-05	200	120	6	bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCell	mild-CD8+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CPA5 TTC3 SAMD9L LAMP3 ATM PCDH10	1.72e-05	200	120	6	c825320599a61a4c629d736f5c0fd6f1f405540a
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GLB1L2 SCN5A SCN9A SORCS3 GNAS	3.75e-05	139	120	5	408bc31aa5e1c2b379f79198fe8b5411f8d7bd08
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SEMA4F ANK3 SAMD9L LAMP3 ADGRF5	6.30e-05	155	120	5	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TUT4 PIWIL4 DMXL1 PCDH10 CCDC33	7.54e-05	161	120	5	8aaca49b53a551395f4025ac4e535c7b0ce41a49
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TUT4 PIWIL4 DMXL1 PCDH10 CCDC33	7.54e-05	161	120	5	deb10628d258fb813c293f81fb71be8e383dc82a
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPA5 ANK3 SRC GRIA2 COCH	8.71e-05	166	120	5	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	COVID-19_Severe-CD4+_T_activated\|COVID-19_Severe / Disease condition and Cell class	CPA5 ANK3 COL22A1 SAMD9L LAMP3	8.71e-05	166	120	5	0f138dbafad6f83975944e8f6398411127b150cc
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPA5 ANK3 SRC GRIA2 COCH	8.71e-05	166	120	5	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 TTC3 FZD4 SCARB2 MAPK6	8.96e-05	167	120	5	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL22A1 GRIN2B HMCN1 PTPRJ SCN9A	9.22e-05	168	120	5	af82e07d1eec51fc6530155f37addbce6221885d
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DENND5B IGHV3-43 IGHV3-23 IGHV3-64D COCH	9.48e-05	169	120	5	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	10x5'-Lung-Lymphocytic_B_plasma\|Lung / Manually curated celltypes from each tissue	DENND5B IGHV3-23 SSR4 IGHV3-64D COCH	1.03e-04	172	120	5	8156fb6de66a4c92ade703b71c2e9187291e50ef
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 RNPC3 RHOBTB3 USP24 HMCN1	1.06e-04	173	120	5	0c74bdb40e635d906fd180412c23bf7fed61621e
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DENND5B IGHV3-43 IGHV3-23 SSR4 IGHV3-64D	1.06e-04	173	120	5	0ca2169a275404118038c0489a48062879488765
ToppCell	CV-Mild-7\|Mild / Virus stimulation, Condition and Cluster	TLK2 DPY19L1 RHOBTB3 GLB1L2 BMP1	1.06e-04	173	120	5	c9bbca9313a0fdf146c8c995624b94b937e818d8
ToppCell	P07-Epithelial-alveolar_epithelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK3 SLC1A5 LLGL2 LAMP3 C5	1.09e-04	174	120	5	2739de68e0266054694f99807cfb1f07b6bbb371
ToppCell	P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SEMA4F ANK3 PIWIL4 LAMP3 C5	1.12e-04	175	120	5	8a4ed775ff973123dbcfe9c809959d11a62450c9
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 LAMA2 GRIA2 GNAS C8B	1.18e-04	177	120	5	1dc69c661e70e7e22bd9d7cf953eb638da9fd43c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 LAMA2 GRIA2 GNAS C8B	1.18e-04	177	120	5	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	STOX1 DNAH7 ADGB EFHC2 C8B	1.21e-04	178	120	5	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.24e-04	179	120	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPY19L1 COL22A1 TENM4 LCN15 SORCS3	1.24e-04	179	120	5	d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 GLB1L2 LRRC43 DNAH7 ADGB	1.27e-04	180	120	5	92fb01b91261b3103454924cde56add337b41844
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.31e-04	181	120	5	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	P03-Epithelial-alveolar_epithelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK3 SLC1A5 LLGL2 LAMP3 C5	1.31e-04	181	120	5	c3dbf8850d3812fbb770798f4cf38908db8bb92b
ToppCell	P03-Epithelial\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK3 SLC1A5 LLGL2 LAMP3 C5	1.31e-04	181	120	5	de0466072f5b2ab8db3d9bab31e3205d1ff7cfb7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 DPY19L1 LLGL2 LAMP3 ADGRF5	1.31e-04	181	120	5	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TUT4 ANK3 TOMM70 SAMD9L LAMP3	1.34e-04	182	120	5	1aea96ee211f7b9caef7fd385233f51be6021a73
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 CHD4 TTC3 SAMD9L TASOR	1.34e-04	182	120	5	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RHOBTB3 USP24 PLEKHD1 HMCN1	1.34e-04	182	120	5	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 CHD4 TTC3 SAMD9L TASOR	1.34e-04	182	120	5	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TUT4 ANK3 TOMM70 SAMD9L LAMP3	1.34e-04	182	120	5	b427e43ee523a3ea9eca3207f3d82042f10f022a
ToppCell	facs-Kidney-nan-3m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRN FZD4 LRRC8A ADGRF5 C8B	1.34e-04	182	120	5	4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUT4 ANK3 TOMM70 SAMD9L LAMP3	1.34e-04	182	120	5	c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.34e-04	182	120	5	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUT4 ANK3 TOMM70 SAMD9L LAMP3	1.34e-04	182	120	5	4cb182ef39be2044a6ad7266f332d4177591e550
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RNPC3 RHOBTB3 PLEKHD1 HMCN1	1.38e-04	183	120	5	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated\|COVID-19_Mild / Disease group, lineage and cell class	TUT4 ANK3 TOMM70 SAMD9L LAMP3	1.38e-04	183	120	5	7717fce227b4e02ed41baad8ae7dd2e22bd7c13e
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	STOX1 LRRC43 DNAH7 ADGB CCDC33	1.38e-04	183	120	5	b1336eac5adbffade4cef3e0ce3de75a781ae365
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	DENND5B IGHV3-23 IGHV3-64D COCH IGHV3-72	1.38e-04	183	120	5	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)\|367C / Donor, Lineage, Cell class and subclass (all cells)	STOX1 LRRC43 DNAH7 ADGB CCDC33	1.38e-04	183	120	5	cc57dcb59c68d68a546dc108dd9e009b2aab8da5
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	DENND5B IGHV3-23 IGHV3-64D COCH IGHV3-72	1.38e-04	183	120	5	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-23 SSR4 IGHV3-64D TMEM258 IGHV3-72	1.38e-04	183	120	5	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.38e-04	183	120	5	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 RHOBTB3 BMP1 LAMP3 C5	1.41e-04	184	120	5	157a3d00165bb4a8c52c3e63ae57d9cf57500be7
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells\|Liver / Manually curated celltypes from each tissue	DENND5B IGHV3-23 SSR4 IGHV3-64D IGHV3-72	1.41e-04	184	120	5	6f70d8f8ab8362d51f8a58735d42223e06566397
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.41e-04	184	120	5	d0c212a8fbaad24597a84018442b25c61c17ea58
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.41e-04	184	120	5	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 DNAH7 ADGB EFHC2 CCDC33	1.45e-04	185	120	5	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.45e-04	185	120	5	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	10x5'-Liver-Lymphocytic_B_plasma\|Liver / Manually curated celltypes from each tissue	DENND5B IGHV3-23 SSR4 IGHV3-64D IGHV3-72	1.48e-04	186	120	5	a2c7430781f432c9c90ac4d620f4518ff767a223
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 STOX1 DNAH7 ADGB CCDC33	1.48e-04	186	120	5	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 GRIA2 PIWIL4 GNAS C8B	1.48e-04	186	120	5	16092819e9148dfe64f07c737652b6e533e699f7
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 GRIA2 SGCE GNAS C8B	1.48e-04	186	120	5	4bb54043f944a979db91bde9a86dd66f498c7658
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.48e-04	186	120	5	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 LLGL2 LAMP3 C5	1.52e-04	187	120	5	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMPRSS15 ANK3 TENM4 SCN5A GNAS	1.52e-04	187	120	5	69b47f00598d647e2a99427ebddf42c339428e47
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	LRRC43 DNAH7 ADGB EFHC2 CCDC33	1.52e-04	187	120	5	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	IPF-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	KIF16B BCR RFTN1 TENM4 LAMP3	1.56e-04	188	120	5	47bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNPC3 RHOBTB3 USP24 PLEKHD1 HMCN1	1.56e-04	188	120	5	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 BMP1 TENM4 LAMP3 C5	1.56e-04	188	120	5	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	ANK3 SCN9A LAMP3 ADGRF5 C5	1.56e-04	188	120	5	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RNPC3 RHOBTB3 USP24 LLGL2 HMCN1	1.60e-04	189	120	5	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DMXL2 SKI SH3PXD2B PLET1 MAPK6	1.60e-04	189	120	5	6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RNPC3 USP24 PLEKHD1 HMCN1	1.60e-04	189	120	5	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DENND5B IGHV3-43 IGHV3-23 SSR4 IGHV3-72	1.60e-04	189	120	5	5a42be62552d912d0abf68f00d75ac80bbd69f2c
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	ANK3 GRIA2 GRIN2B SCN9A PCDH10	1.64e-04	190	120	5	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-43 IGHV3-23 SSR4 IGHV3-64D IGHV3-72	1.64e-04	190	120	5	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-43 IGHV3-23 SSR4 IGHV3-64D IGHV3-72	1.64e-04	190	120	5	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 LAMA2 GRIA2 GNAS C8B	1.64e-04	190	120	5	db19c72d8c8053262b535068c5a9d4d696989cb1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 RNPC3 USP24 PLEKHD1 HMCN1	1.64e-04	190	120	5	e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RHOBTB3 LAMA2 BMP1 HMCN1 SGCE	1.68e-04	191	120	5	9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|lung / Disease (COVID-19 only), tissue and cell type	DMXL2 DOCK11 MYO9B KIF16B SH3PXD2B	1.68e-04	191	120	5	dab953682b8c9ed680a799161f837f792a7e4f33
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B TUT4 DMXL1 PTK2B PTPRJ	1.72e-04	192	120	5	2de242d81dc085ae734eb7d1f091af9a542e0866
ToppCell	LV-08._Macrophage\|LV / Chamber and Cluster_Paper	DOCK11 PTK2B SH3PXD2B PTPRJ SCN9A	1.72e-04	192	120	5	7be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEMA4F ANK3 PLEKHD1 LAMP3 ADGRF5	1.72e-04	192	120	5	13e4b17d7a592604140777aca235f795df6b3f91
ToppCell	Ciliated-cil-3\|World / Class top	DYNC2H1 LRRC43 ADGB PLET1 CCDC33	1.72e-04	192	120	5	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEMA4F ANK3 PLEKHD1 LAMP3 ADGRF5	1.72e-04	192	120	5	f51b3fd962263920a6cae783ca7af13f5eb7aaa3
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B TUT4 DMXL1 PTK2B PTPRJ	1.72e-04	192	120	5	ba2a683472a8b785dbf666dc6e94356d879486c3
Drug	naringenin chalcone	UGT1A8 UGT1A7 UGT1A9	1.28e-06	5	116	3	ctd:C027329
Drug	anthrarobin	UGT1A8 UGT1A7 UGT1A9	1.28e-06	5	116	3	ctd:C032186
Drug	6-hydroxychrysene	UGT1A8 UGT1A7 UGT1A9 BCR	1.45e-06	17	116	4	CID000037766
Drug	lamotrigine	UGT1A8 UGT1A7 UGT1A9 GRIA2 GRIN2B SCN5A SCN9A	2.19e-06	116	116	7	CID000003878
Drug	1,2,5,8-tetrahydroxy anthraquinone	UGT1A8 UGT1A7 UGT1A9	2.55e-06	6	116	3	ctd:C543211
Drug	alloin	UGT1A8 UGT1A7 UGT1A9	2.55e-06	6	116	3	ctd:C006457
Drug	2',5'-dihydroxychalcone	UGT1A8 UGT1A7 UGT1A9	2.55e-06	6	116	3	ctd:C107497
Drug	2',4'-dihydroxychalcone	UGT1A8 UGT1A7 UGT1A9	4.44e-06	7	116	3	ctd:C059354
Drug	1,4-dihydroxyanthraquinone	UGT1A8 UGT1A7 UGT1A9	7.08e-06	8	116	3	ctd:C034890
Drug	AC1MRQNQ	UGT1A8 UGT1A7 UGT1A9	1.06e-05	9	116	3	CID003522271
Drug	DHPASiU	UGT1A8 UGT1A7 UGT1A9	1.06e-05	9	116	3	CID000197602
Drug	3-iodophenol	UGT1A8 UGT1A7 UGT1A9	1.06e-05	9	116	3	CID000012272
Drug	AC1L4J7U	UGT1A8 UGT1A7 UGT1A9	1.06e-05	9	116	3	CID000186631
Drug	Chebi:32663	UGT1A8 UGT1A7 UGT1A9	1.06e-05	9	116	3	CID005460873
Drug	levo-dromoran tartrate	UGT1A8 UGT1A7 UGT1A9 GRIA2 GRIN2B GNAS	1.10e-05	98	116	6	CID000003918
Drug	erucin	UGT1A8 UGT1A7 UGT1A9 NLRP1	1.19e-05	28	116	4	CID000078160
Drug	2,6-dihydroxyanthraquinone	UGT1A8 UGT1A7 UGT1A9	1.51e-05	10	116	3	ctd:C034889
Drug	dihydroartemisinin	UGT1A8 UGT1A7 UGT1A9 ATM	1.58e-05	30	116	4	CID000107770
Drug	AC1L1DK5	SET REN MTA1 MTA3	2.06e-05	32	116	4	CID000002384
Drug	indole-2-carboxylic acid	UGT1A8 UGT1A7 UGT1A9 GRIN2B	2.06e-05	32	116	4	CID000072899
Drug	4-nitrophenyl)imidazole	UGT1A8 UGT1A7 UGT1A9	2.06e-05	11	116	3	CID000123155
Drug	AC1O5XMV	UGT1A8 UGT1A7 UGT1A9	2.06e-05	11	116	3	CID006442661
Drug	R(-)-Denopamine	UGT1A8 UGT1A7 UGT1A9 SCN5A	2.34e-05	33	116	4	CID000003818
Drug	ms37	TLK2 TLK1	2.57e-05	2	116	2	CID016122503
Drug	Ranolazine	SCN5A SCN9A	2.57e-05	2	116	2	DB00243
Drug	Z 338	UGT1A8 UGT1A9	2.57e-05	2	116	2	ctd:C410959
Drug	valproate	ATRN UGT1A8 UGT1A7 UGT1A9 NLRP1 BCR MTA1 SCN9A SGCE MAPK6	2.59e-05	381	116	10	CID000003121
Drug	N-OH-DABZ	UGT1A8 UGT1A7 UGT1A9	2.74e-05	12	116	3	CID000051366
Drug	1-O-beta-D-glucopyranosyl-D-mannitol	UGT1A8 UGT1A7 UGT1A9	2.74e-05	12	116	3	CID000088735
Drug	4-hydroxyestrone	UGT1A8 UGT1A7 UGT1A9	2.74e-05	12	116	3	ctd:C026418
Drug	2,4,6-TCB	UGT1A8 UGT1A7 UGT1A9	2.74e-05	12	116	3	CID000037247
Drug	nonanoyl-N-methylglucamide	UGT1A8 UGT1A7 UGT1A9	2.74e-05	12	116	3	CID000160090
Drug	7,7,7-triphenylheptanoic acid	UGT1A8 UGT1A7 UGT1A9	2.74e-05	12	116	3	CID000276709
Drug	AC1L9DGV	UGT1A8 UGT1A7 UGT1A9 NLRP1	3.32e-05	36	116	4	CID000417381
Drug	2-hydroxyestrone	UGT1A8 UGT1A7 UGT1A9	3.55e-05	13	116	3	ctd:C024980
Drug	tritanol	UGT1A8 UGT1A7 UGT1A9	3.55e-05	13	116	3	CID000006457
Drug	5-azido-UDP-glucuronic acid	UGT1A8 UGT1A7 UGT1A9	3.55e-05	13	116	3	CID003081279
Drug	cotinine-N-glucuronide	UGT1A8 UGT1A7 UGT1A9	3.55e-05	13	116	3	CID000000411
Drug	alizarin	UGT1A8 UGT1A7 UGT1A9	3.55e-05	13	116	3	ctd:C010078
Drug	Propofol	UGT1A8 UGT1A7 UGT1A9 GRIA2 REN	4.36e-05	76	116	5	ctd:D015742
Drug	propranolol glucuronide	UGT1A8 UGT1A7 UGT1A9	4.50e-05	14	116	3	CID000119515
Drug	PCB-61	UGT1A8 UGT1A7 UGT1A9	4.50e-05	14	116	3	CID000036401
Drug	Tetrodotoxin	GRIA2 GRIN2B SCN5A SCN9A	5.07e-05	40	116	4	ctd:D013779
Drug	2,2',3,5,5'-pentachlorobiphenyl	UGT1A8 UGT1A7 UGT1A9	5.61e-05	15	116	3	CID000040469
Drug	afloqualone	UGT1A8 UGT1A7 UGT1A9	5.61e-05	15	116	3	CID000002040
Drug	naphthyl sulphate	UGT1A8 UGT1A7 UGT1A9	5.61e-05	15	116	3	CID000114775
Drug	coumarin-3-carboxylic acid	UGT1A8 UGT1A7 UGT1A9	5.61e-05	15	116	3	CID000010752
Drug	bergamottin	UGT1A8 UGT1A7 UGT1A9	5.61e-05	15	116	3	ctd:C068337
Drug	sulforaphane nitrile	UGT1A8 UGT1A7 UGT1A9	5.61e-05	15	116	3	CID000543743
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A	RASA2 SKI BCR BMP1 RFTN1 MTA1 BTBD7	6.44e-05	195	116	7	3512_DN
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT_HG-U133A	DENND5B DYNC2H1 NLRP1 PTK2B TLK1 MTA1 SCARB2	6.44e-05	195	116	7	2740_DN
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ATRN DYNC2H1 GLB1L2 BMP1 RFTN1 COCH SCARB2	6.65e-05	196	116	7	7022_DN
Drug	Chlorogenic acid [327-97-9]; Up 200; 11.2uM; HL60; HT_HG-U133A	TUT4 TAPT1 BCR PTK2B MTA1 BTBD7 C5	6.65e-05	196	116	7	1346_UP
Drug	Flumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A	MAN2A2 MYO9B BCR ADGB BMP1 MTA1 SCN5A	6.87e-05	197	116	7	5529_UP
Drug	Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A	DENND5B EFCAB11 ANK3 DYNC2H1 ADGB SCN5A GNAS	6.87e-05	197	116	7	3019_DN
Drug	quercetin-3,4'-diglucoside	UGT1A8 UGT1A7 UGT1A9	6.88e-05	16	116	3	CID005320835
Drug	1'-hydroxyestragole	UGT1A8 UGT1A7 UGT1A9	6.88e-05	16	116	3	CID000040003
Drug	bilirubin-phosphate	UGT1A8 UGT1A7 UGT1A9	6.88e-05	16	116	3	CID005497144
Drug	AC1L1H8N	GRIA2 GRIN2B	7.69e-05	3	116	2	CID000004023
Drug	Li-Y	REN KY	7.69e-05	3	116	2	CID011963546
Drug	7-chlorokynurenic acid	GRIA2 GRIN2B SLC1A5 KY	8.11e-05	45	116	4	CID000001884
Drug	3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one	UGT1A8 UGT1A7 UGT1A9	8.32e-05	17	116	3	CID000003573
Drug	nogalonic acid methyl ester	UGT1A8 UGT1A7 UGT1A9 NLRP1 GNAS	8.34e-05	87	116	5	CID000443820
Drug	SureCN12722713	UGT1A8 UGT1A7 UGT1A9	9.94e-05	18	116	3	CID005488034
Drug	ethyl-beta-D-6-glucosiduronic acid	UGT1A8 UGT1A7 UGT1A9	9.94e-05	18	116	3	CID000152226
Drug	Br 2	UGT1A8 UGT1A7 UGT1A9	9.94e-05	18	116	3	CID003060900
Drug	2,3,7-trichlorodibenzo-p-dioxin	UGT1A8 UGT1A7 UGT1A9	9.94e-05	18	116	3	CID000036614
Drug	ApApG	UGT1A8 UGT1A7 UGT1A9	9.94e-05	18	116	3	CID003081975
Drug	C1 11-32	UGT1A8 UGT1A7 UGT1A9	9.94e-05	18	116	3	CID000443077
Drug	C11131	UGT1A8 UGT1A7 UGT1A9	9.94e-05	18	116	3	CID000443076
Drug	succinamide	VIPR1 REN SLC1A5	9.94e-05	18	116	3	CID000008036
Drug	isoamyl alcohol	UGT1A8 UGT1A7 UGT1A9 REN	1.05e-04	48	116	4	CID000031260
Drug	retigabine	ANK3 UGT1A8 UGT1A7 UGT1A9	1.05e-04	48	116	4	CID000121892
Drug	AC1L1G0K	VIPR1 UGT1A8 UGT1A7 UGT1A9	1.14e-04	49	116	4	CID000003473
Drug	EM-652	UGT1A8 UGT1A7 UGT1A9 SCARB2	1.14e-04	49	116	4	CID000155435
Drug	9-OH-risperidone	UGT1A8 UGT1A7 UGT1A9	1.18e-04	19	116	3	CID000475100
Drug	5alpha-spirostan-3beta-ol	UGT1A8 UGT1A7 UGT1A9	1.18e-04	19	116	3	CID000091433
Drug	almokalant	UGT1A8 UGT1A7 UGT1A9	1.18e-04	19	116	3	CID003033962
Drug	tectochrysin	UGT1A8 UGT1A7 UGT1A9	1.38e-04	20	116	3	CID005281954
Drug	AC1L1OBF	UGT1A8 UGT1A7 UGT1A9	1.38e-04	20	116	3	CID000032736
Drug	4'-hydroxydiclofenac	UGT1A8 UGT1A7 UGT1A9	1.38e-04	20	116	3	CID000116545
Drug	entacapone	UGT1A8 UGT1A7 UGT1A9	1.38e-04	20	116	3	ctd:C071192
Drug	mepyramine	UGT1A8 UGT1A7 UGT1A9 ATM GNAS MAPK6	1.40e-04	154	116	6	CID000004992
Drug	AC1NQGK1	UGT1A8 UGT1A7 UGT1A9 GRIN2B	1.43e-04	52	116	4	CID005195977
Drug	sitafloxacin	UGT1A7 UGT1A9	1.53e-04	4	116	2	ctd:C076246
Drug	Lidocaine	SCN5A SCN9A	1.53e-04	4	116	2	DB00281
Drug	hydratropic acid	UGT1A8 UGT1A7	1.53e-04	4	116	2	ctd:C013025
Drug	2-vanillin	UGT1A8 UGT1A7	1.53e-04	4	116	2	ctd:C060843
Drug	tolamolol	SET REN	1.53e-04	4	116	2	CID000037910
Drug	diphenylacetic acid	UGT1A8 UGT1A7	1.53e-04	4	116	2	ctd:C037760
Drug	estriol-16-glucuronide	UGT1A8 UGT1A7 UGT1A9	1.60e-04	21	116	3	CID000122281
Drug	CX546	GRIA2 GRIN2B BMP1	1.60e-04	21	116	3	CID000002890
Drug	7-hydroxycoumarin	UGT1A8 UGT1A7 UGT1A9	1.60e-04	21	116	3	ctd:C031477
Drug	dulcin	UGT1A8 UGT1A7 UGT1A9	1.60e-04	21	116	3	CID000009013
Drug	Benzamidoxime hydrochloride	UGT1A8 UGT1A7 UGT1A9	1.60e-04	21	116	3	CID000069186
Drug	Equol	UGT1A8 UGT1A7 SRC UGT1A9	1.66e-04	54	116	4	ctd:D060754
Drug	amonafide	UGT1A8 UGT1A7 UGT1A9	1.85e-04	22	116	3	CID000050515
Drug	N-methylpiperazine	UGT1A8 UGT1A7 UGT1A9	1.85e-04	22	116	3	CID000053167
Drug	plumbagin	UGT1A8 UGT1A7 UGT1A9	1.85e-04	22	116	3	ctd:C014758
Drug	Invader	UGT1A8 UGT1A7 UGT1A9 COCH	1.92e-04	56	116	4	CID006442259
Disease	N-acetyl-4-chlorophenylalanine measurement	UGT1A8 UGT1A7 UGT1A9	5.89e-07	5	116	3	EFO_0801060
Disease	5-hydroxyindole sulfate measurement	UGT1A8 UGT1A7 UGT1A9	5.89e-07	5	116	3	EFO_0800085
Disease	nuclear receptor subfamily 1 group D member 2 measurement	UGT1A8 UGT1A7 UGT1A9	5.89e-07	5	116	3	EFO_0801853
Disease	X-21339 measurement	UGT1A8 UGT1A7 UGT1A9	2.05e-06	7	116	3	EFO_0800808
Disease	X-11793--oxidized bilirubin measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0021260
Disease	Succinimide measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0022118
Disease	X-11530 measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0800696
Disease	X-10458 measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0800692
Disease	X-24849 measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0800909
Disease	serum N-desmethylclozapine measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0600043
Disease	plasma clozapine measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0600038
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0802740
Disease	X-16946 measurement	UGT1A8 UGT1A7 UGT1A9	3.27e-06	8	116	3	EFO_0800766
Disease	X-11442 measurement	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0021236
Disease	X-11441 measurement	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0801036
Disease	X-11880 measurement	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0802127
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A8 UGT1A7 UGT1A9	4.89e-06	9	116	3	EFO_0004570, GO_0009410
Disease	response to dolutegravir	UGT1A8 UGT1A7 UGT1A9 PCDH10	5.74e-06	30	116	4	EFO_0600017
Disease	bilirubin measurement, response to tenofovir	UGT1A8 UGT1A7 UGT1A9	6.96e-06	10	116	3	EFO_0004570, EFO_0009279
Disease	X-21448 measurement	UGT1A8 UGT1A7 UGT1A9	6.96e-06	10	116	3	EFO_0800816
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A8 UGT1A7 UGT1A9	6.96e-06	10	116	3	EFO_0802185
Disease	X-23974 measurement	UGT1A8 UGT1A7 UGT1A9	6.96e-06	10	116	3	EFO_0800867
Disease	pregnenetriol sulfate measurement	UGT1A8 UGT1A7 UGT1A9	9.55e-06	11	116	3	EFO_0800586
Disease	plasma N-desmethylclozapine measurement	UGT1A8 UGT1A7 UGT1A9	9.55e-06	11	116	3	EFO_0600039
Disease	histidine betaine (hercynine) measurement	UGT1A8 UGT1A7 UGT1A9	9.55e-06	11	116	3	EFO_0800972
Disease	X-21796 measurement	UGT1A8 UGT1A7 UGT1A9	9.55e-06	11	116	3	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A8 UGT1A7 UGT1A9	9.55e-06	11	116	3	EFO_0004570, EFO_0004698
Disease	aldosterone measurement	UGT1A8 UGT1A7 UGT1A9	9.55e-06	11	116	3	EFO_0010219
Disease	p-cresol glucuronide measurement	UGT1A8 UGT1A7 UGT1A9	1.27e-05	12	116	3	EFO_0800079
Disease	biliverdin measurement	UGT1A8 UGT1A7 UGT1A9	1.27e-05	12	116	3	EFO_0021033
Disease	pregnenetriol disulfate measurement	UGT1A8 UGT1A7 UGT1A9	1.65e-05	13	116	3	EFO_0800587
Disease	retinol dehydrogenase 16 measurement	UGT1A8 UGT1A7 UGT1A9	1.65e-05	13	116	3	EFO_0802007
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A8 UGT1A7 UGT1A9	3.87e-05	17	116	3	EFO_0004611, EFO_0007800
Disease	X-21441 measurement	UGT1A8 UGT1A7 UGT1A9	3.87e-05	17	116	3	EFO_0800814
Disease	indole-3-carboxylate measurement	UGT1A8 UGT1A9	4.58e-05	3	116	2	EFO_0800043
Disease	blood 4-oxo-retinoic acid measurement	UGT1A8 UGT1A9	4.58e-05	3	116	2	EFO_0022216
Disease	angiopoietin-related protein 1 measurement	UGT1A8 UGT1A7 UGT1A9	4.63e-05	18	116	3	EFO_0801382
Disease	status epilepticus (biomarker_via_orthology)	ANK3 GRIA2 PTK2B SLC8A2 ATM	4.81e-05	100	116	5	DOID:1824 (biomarker_via_orthology)
Disease	tissue factor measurement	UGT1A8 UGT1A7 UGT1A9	7.48e-05	21	116	3	EFO_0010623
Disease	urate measurement, spine bone mineral density	UGT1A8 UGT1A7 SRC UGT1A9	8.17e-05	58	116	4	EFO_0004531, EFO_0007701
Disease	attention deficit hyperactivity disorder	DENND5B MAN2A2 UGT1A8 UGT1A9 TENM4 MTA3 SORCS3 TMX3	8.18e-05	354	116	8	EFO_0003888
Disease	Immunologic Deficiency Syndromes	C5 ATM C8B	9.90e-05	23	116	3	C0021051
Disease	Grand Mal Status Epilepticus	ANK3 SRC GRIA2 PTK2B	1.44e-04	67	116	4	C0311335
Disease	Status Epilepticus, Subclinical	ANK3 SRC GRIA2 PTK2B	1.44e-04	67	116	4	C0751522
Disease	Simple Partial Status Epilepticus	ANK3 SRC GRIA2 PTK2B	1.44e-04	67	116	4	C0751524
Disease	Non-Convulsive Status Epilepticus	ANK3 SRC GRIA2 PTK2B	1.44e-04	67	116	4	C0751523
Disease	Petit mal status	ANK3 SRC GRIA2 PTK2B	1.44e-04	67	116	4	C0270823
Disease	Complex Partial Status Epilepticus	ANK3 SRC GRIA2 PTK2B	1.44e-04	67	116	4	C0393734
Disease	Status Epilepticus	ANK3 SRC GRIA2 PTK2B	1.52e-04	68	116	4	C0038220
Disease	neuroblastoma, cutaneous melanoma	UGT1A8 UGT1A7 UGT1A9	1.81e-04	28	116	3	EFO_0000389, EFO_0000621
Disease	Schizophrenia	EFCAB11 ANK3 MYO9B LAMA2 GRIA2 CHD4 GRIN2B ADNP TENM4 ATM GNAS DNMT3L	1.91e-04	883	116	12	C0036341
Disease	xanthurenate measurement	UGT1A8 UGT1A7 UGT1A9	2.01e-04	29	116	3	EFO_0010551
Disease	3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement	UGT1A8 UGT1A9	2.27e-04	6	116	2	EFO_0800566
Disease	vitamin D deficiency	UGT1A8 UGT1A7 UGT1A9	4.17e-04	37	116	3	EFO_0003762
Disease	Neurodevelopmental Disorders	GRIN2B ADNP WDFY3 ALG13	5.06e-04	93	116	4	C1535926
Disease	Colon Carcinoma	SRC PTPRJ	5.42e-04	9	116	2	C0699790
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN5A SCN9A	6.75e-04	10	116	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN5A SCN9A	6.75e-04	10	116	2	DOID:0080422 (implicated_via_orthology)
Disease	indoleacetate measurement	UGT1A8 UGT1A9	6.75e-04	10	116	2	EFO_0021015
Disease	mean platelet volume	SEMA4F SET DOCK11 MYO9B KIF16B TLK1 COCH PTPRJ LRRC8A ADGRF5 GNAS TASOR	6.94e-04	1020	116	12	EFO_0004584
Disease	vitamin D measurement, COVID-19	UGT1A8 UGT1A7 UGT1A9	9.56e-04	49	116	3	EFO_0004631, MONDO_0100096
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN5A SCN9A	9.86e-04	12	116	2	DOID:0060170 (implicated_via_orthology)
Disease	X-24588 measurement	UGT1A8 UGT1A9	1.16e-03	13	116	2	EFO_0800898
Disease	rostral middle frontal gyrus volume measurement	ADGB MAPK6	1.35e-03	14	116	2	EFO_0010328
Disease	colorectal cancer (is_implicated_in)	SRC CHD4 PTPRJ ATM	1.35e-03	121	116	4	DOID:9256 (is_implicated_in)
Disease	Withdrawal Symptoms	GRIA2 REN GNAS	1.56e-03	58	116	3	C0087169
Disease	Drug Withdrawal Symptoms	GRIA2 REN GNAS	1.56e-03	58	116	3	C0086189
Disease	Substance Withdrawal Syndrome	GRIA2 REN GNAS	1.56e-03	58	116	3	C0038587
Disease	response to antipsychotic drug	DYNC2H1 COL22A1 TENM4	1.72e-03	60	116	3	GO_0097332
Disease	bone mineral content measurement	NLRP1 ABRAXAS2 PTK2B MTA3	1.76e-03	130	116	4	EFO_0007621
Disease	Intellectual Disability	TLK2 SET GRIA2 GRIN2B KLHL15 GNAS ALG13	1.98e-03	447	116	7	C3714756
Disease	retinopathy	SRC TENM4	2.00e-03	17	116	2	EFO_0003839
Disease	Antibody Deficiency Syndrome	C5 C8B	2.00e-03	17	116	2	C0003257
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TLK2 SET	2.00e-03	17	116	2	DOID:0060307 (is_implicated_in)
Disease	Fetal Alcohol Syndrome	ANK3 ADNP	2.00e-03	17	116	2	C0015923
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	PTPRJ ATM	2.51e-03	19	116	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	PTPRJ ATM	2.51e-03	19	116	2	C2936783
Disease	Bipolar Disorder	ANK3 GRIA2 REN GRIN2B BCR FZD4 TENM4	2.84e-03	477	116	7	C0005586
Disease	gastric ulcer	MYO9B GNAS	3.06e-03	21	116	2	EFO_0009454
Disease	esophagus squamous cell carcinoma (is_marker_for)	SLC1A5 EHMT2 ATM	3.13e-03	74	116	3	DOID:3748 (is_marker_for)
Disease	serum gamma-glutamyl transferase measurement	ATRN DOCK11 UGT1A8 UGT1A7 UGT1A9 NLRP1 SKI SH3PXD2B TENM4 LSM14B	3.29e-03	914	116	10	EFO_0004532
Disease	unipolar depression, bipolar disorder	ANK3 TENM4 SORCS3 TMEM258	3.40e-03	156	116	4	EFO_0003761, MONDO_0004985
Disease	Alzheimer's disease (is_marker_for)	GRIN2B STOX1 SLC8A2 ATM GNAS	3.53e-03	257	116	5	DOID:10652 (is_marker_for)
Disease	frailty measurement	ANK3 MAPK6	3.67e-03	23	116	2	EFO_0009885

Protein segments in the cluster

Peptide	Gene	Start	Entry
DDSYEARKSFLTKYF	ADNP	761	Q9H2P0
LVSAAFRSYSTTYEE	SLC1A5	196	Q15758
FSFYDYASKVNEESL	ABRAXAS2	66	Q15018
FSTESFTLDVYRYKD	ALG13	51	Q9NP73
FESYVEGSFEKYLER	ALG13	276	Q9NP73
FSERVYTEKDYGTIY	ANKRD30B	21	Q9BXX2
ATSFSEDTALVLEYY	CCDC33	481	Q8N5R6
LREYFKYFSTELTSS	DNMT3L	371	Q9UJW3
SEFKFSEERVSYYLF	ADGB	661	Q8N7X0
SEERVSYYLFVDSLK	ADGB	666	Q8N7X0
GKSYTFLISSDYERA	BCR	841	P11274
DLSSGFSKYRDFIRY	FBXW10	266	Q5XX13
SLYYDSYSVDERVDS	EHMT2	271	Q96KQ7
RLYESEFETSSTYIS	DMXL2	1756	Q8TDJ6
FLERTDEDSYIVFTY	BMP1	166	P13497
YESEFDTSAAYKSIL	DMXL1	1731	Q9Y485
ERTKTFTYDFSFYSA	KIF16B	51	Q96L93
LRFADDTYTESYIST	RAB1B	26	Q9H0U4
FNEIFYFEVTRSSSY	RASA2	221	Q15283
KIDVSYEYRFLEFTT	RFTN1	31	Q14699
YEYRFLEFTTLSAAE	RFTN1	36	Q14699
YSFESIREESSYSDI	LRRC8A	351	Q8IWT6
TLSYKYRDLDSTFSS	RADIL	31	Q96JH8
DLSSGFSKYRDFIRY	FBXW10B	266	O95170
AESYVSFSRYSDAVS	PTPRJ	951	Q12913
SYTTEYAASVKGRFT	IGHV3-72	76	A0A0B4J1Y9
STYYADSVKGRFTIS	IGHV3-43D	76	P0DP04
GFVRTLYFADTYLKD	LLGL2	711	Q6P1M3
FEFSETYLAVLYDST	MTMR10	481	Q9NXD2
SEEERARYFSSYFTD	NLRP10	316	Q86W26
ARYFSSYFTDEKQAD	NLRP10	321	Q86W26
DTITSKFTFLYNEFY	KY	291	Q8NBH2
YYDKSKSFFDNISSE	LSM14B	311	Q9BX40
TFSLSQEDDRYYTAI	ATRN	1166	O75882
KLSFDDFNTYYTDIL	TMPRSS15	266	P98073
YDSGIKYAFSFELRD	CPA5	386	Q8WXQ8
FDTFIYSCVYEDREK	EFHC2	636	Q5JST6
DKFAYLYDSDRGLST	GRIA2	146	P42262
KENTYTSYLDKFFSR	MAPK6	621	Q16659
FSESSRKEYFYRYFT	NLRP1	481	Q9C000
SKFFSYKDFDTLLYT	DPY19L1	376	Q2PZI1
VLREKIYSTAFDYFS	PI4KAP1	116	Q8N8J0
NLTFTKDEESYYISE	LAMP3	291	Q9UQV4
AIYFEAREETGFSTY	LAMA2	1256	P24043
STYYADSVKGRFTIS	IGHV3-64D	76	A0A0J9YX35
YLDVRIVDTDYSSFA	LCN15	106	Q6UWW0
YALRSFDYEQLKDFS	PCDH10	526	Q9P2E7
STYYADSVKGRFTIS	IGHV3-43	76	A0A0B4J1X8
YKFSSKLNYDTVTFD	RBBP6	6	Q7Z6E9
GSFIYVFTDARSKDY	HMCN1	136	Q96RW7
YDAGLYSRSAKEFTD	FZD4	206	Q9ULV1
TKFYEFSLSDLRAGY	DYNC2H1	3886	Q8NCM8
DEKTYYSLITSFSEL	ENOPH1	241	Q9UHY7
RDREFSTFYESLKYA	ATM	2136	Q13315
SVFEKVKTSEFYRYS	KLHL15	231	Q96M94
ETFYSTERYDITNDK	KLHL15	391	Q96M94
EGLDSYLRSFIKYSF	DOCK11	906	Q5JSL3
FDSETAVKELSYYSL	C5	301	P01031
LESYAKQSEEFYSFG	DNAH7	696	Q8WXX0
RTYGFVLTFYEEVTS	DENND5B	111	Q6ZUT9
SKIEDYFPEFARYTT	GNAS	306	P63092
DRSVFPDTYFSYKVD	ANK3	3511	Q12955
DEYAFVTTFRFRKTS	COL22A1	291	Q8NFW1
YYDVVLSFSSDSELV	BTBD7	246	Q9P203
STYYADSVKGRFTIS	IGHV3-23	76	P01764
FGTLSDYFDALYKRT	MAN2A2	461	P49641
RTTYKGFTEAVDLYF	GLB1L2	161	Q8IW92
SRYIEDEDYYKASVT	PTK2B	571	Q14289
VFSEEDYRTLTNYKA	CHD4	166	Q14839
FTYDQRTEFSFTDYS	COCH	411	O43405
TAFDTYYRGFLTLED	EFCAB11	101	Q9BUY7
LKEYESYSDFERNVT	C8B	231	P07358
EEYLFYFTSDNSLKS	FPGT	376	O14772
DTFFYSYFRSLRVID	LRRC43	121	Q8N309
ISFDREKQESYTFYV	PCDH11Y	661	Q9BZA8
VSKETFLSFLEYLYT	RHOBTB3	466	O94955
LSYLDKEDTFFYSLV	MTA3	121	Q9BTC8
VTTFVALYDYESRTE	SRC	86	P12931
ALYDYESRTETDLSF	SRC	91	P12931
EIYFFFTETSRAFDS	SEMA4F	246	O95754
SLKSDFYRYDIDTNT	MKLN1	356	Q9UL63
SSDEGATYQKYRLTF	SORCS3	281	Q9UPU3
SSENYSSDFVKRDSY	SAMD9L	701	Q8IVG5
KEYTLTSADYVFQES	REN	341	P00797
SYFERKLLFSADVSY	PIWIL4	251	Q7Z3Z4
EYTFTAIYTFESLVK	SCN5A	161	Q14524
EYTFTGIYTFESLVK	SCN9A	156	Q15858
TEFEDIKSGYRIDFY	SETSIP	136	P0DME0
TEFEDIKSGYRIDFY	SET	126	Q01105
SDFCRSVYITFSDYE	SCARB2	271	Q14108
SLKSYLEREDFFFYS	MTA1	136	Q13330
VLREKIYSTAFDYFS	PI4KAP2	116	A4QPH2
DSLKSRDYYTDFLIT	SGCE	306	O43556
IRDSFYSYKSFETAV	SKI	401	P12755
YTFSSIEREEYGKLF	SSRP1	401	Q08945
NYFLSAYTESLDRDK	TASOR	1636	Q9UK61
IVKLYDYFSLDTDSF	TLK2	526	Q86UE8
TSYYRYIEKSAEELD	BRPF1	196	P55201
SALYRSYKTDLETAF	ADGRF5	191	Q8IZF2
TFDEYYTITLDIKAS	PLET1	36	Q6UQ28
ASELIVYTYFFSASE	TMX3	171	Q96JJ7
DSFYTDSSSILNYRE	UHRF1BP1L	1001	A0JNW5
VKLYDYFSLDTDTFC	TLK1	521	Q9UKI8
YFSLDTDTFCTVLEY	TLK1	526	Q9UKI8
VYSYFEKETLTFRDV	ZNF431	26	Q8TF32
YTLLAVSFFSERKYF	VIPR1	241	P32241
FVVEDDKSFYYLASF	TMPRSS11F	51	Q6ZWK6
YLYKVATDSFDSRAE	WDFY3	771	Q8IZQ1
LKYIFGRYVDFSSET	RNPC3	436	Q96LT9
FFIIKESFLLYYSES	PLEKHD1	51	A6NEE1
SYDFTSLSREELLYK	SAGE2P	476	A6NJ88
TYEVRFFDEESYSLL	SSR4	101	P51571
DERIFDYYSARKASF	STOX1	851	Q6ZVD7
GSTEAIYRRYSKFFD	SH3PXD2B	36	A1X283
EFSKERFDIAIIYYT	TTC3	241	P53804
AETLYDTTKVSFTYD	TENM4	2021	Q6N022
FIKSYFSSFTDDIIS	TOMM70	256	O94826
TYSTSYTLEDLDREF	UGT1A9	76	O60656
RDVYSSDYFSFVLSL	USP24	2131	Q9UPU5
TKFNDITADVYSEYR	TAPT1	361	Q6NXT6
YSEYRASLAFDLVSS	TAPT1	371	Q6NXT6
FFVYEVTSTKYTRDI	TMEM258	36	P61165
YTEEFDFKEYVISIR	TUT4	1196	Q5TAX3
TRYSTFSEIFNKEYP	TKTL1	316	P51854
ESSVRKTGSYIYEEF	PPIP5K1	236	Q6PFW1
TYSTSYTLEDQDREF	UGT1A7	76	Q9HAW7
EFFVSEDEKYYLRSL	TYW5	96	A2RUC4
TYSTSYTLEDLDREF	UGT1A8	76	Q9HAW9
TFYVDYRTEDGSAKA	SLC8A2	426	Q9UPR5
RSGYSAKYTFQDFTE	MYO9B	886	Q13459
SDLYGKFSFKSDRYS	GRIN2B	1036	Q13224